1 / 3

Acromegaly Market Insights and Epidemiology Forecast

Acromegaly is a rare, slowly progressive, acquired disorder that affects adults. The pituitary gland produces too much growth hormone (GH). The pituitary gland is a small gland located near the base of the skull that stores several hormones and releases them into the bloodstream as needed by the body. These hormones regulate many different bodily functions.

xmichael
Download Presentation

Acromegaly Market Insights and Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acromegaly Epidemiology Forecast Market Insights and Acromegaly is a rare, slowly progressive, acquired disorder that affects adults. The pituitary gland produces too much growth hormone (GH). The pituitary gland is a small gland located near the base of the skull that stores several hormones and releases them into the bloodstream as needed by the body. These hormones regulate many different bodily functions. In most patients, acromegaly is caused by the growth of a benign tumor (adenoma) arising from the pituitary gland. Symptoms of acromegaly include

  2. abnormal enlargement in bones of the hands, arms, feet, legs, and head. Enlargement of the bones in the jaws and the front of the skull are typically the most apparent bony changes. Acromegaly Epidemiology Segmentation in the 7MM ● ● ● ● ● Total Diagnosed prevalent Cases of Acromegaly Total Tumor origin-specific Cases of Acromegaly Total Gender-specific Cases of Acromegaly Total Tumor size Cases of Acromegaly Total Treated Cases of Acromegaly Acromegaly Epidemiological Insights Observed in the 7MM (2021) ● ● The total diagnosed prevalent cases of Acromegaly in the 7MM were found to be 57.8k. The total Gender-specific cases of Acromegaly in the 7MM where males were found to be 27.5k and the females were estimated to be 30.2k. The total tumor size cases of Acromegaly in the 7MM where macroadenomas were found to be 46.4k and microadenomas were estimated to be 11.4k. ● Acromegaly Market Insight The market size of Acromegaly in the 7MM was found to be USD 1,326.6 million in 2021. Acromegaly Market Drivers ● ● ● Increasing prevalence of acromegaly Incentives for orphan drug designation More efficacious mono and combination therapies Acromegaly Market Barriers ● ● ● High cost of treatment Challenges associated with current treatment Entry of generics in the acromegaly market Acromegaly Emerging Therapies The emerging drugs in the Acromegaly market are ● ● ● Paltusotine (CRN 00808) CAM-2029 (octreotide subcutaneous depot) Cimdelirsen/IONIS-GHR-LRx, and many others Acromegaly Key Players The key players working in the Acromegaly market are ● Crinetics Pharmaceuticals

  3. ● ● Camurus Ionis Pharmaceuticals, and several others

More Related